tiprankstipranks
Trending News
More News >
Monte Rosa Therapeutics (GLUE)
NASDAQ:GLUE
US Market
Advertisement

Monte Rosa Therapeutics (GLUE) Technical Analysis

Compare
335 Followers

Technical Sentiment

Overall Consensus
Buy
13Bullish
4Neutral
5Bearish
Technical Analysis Consensus
Neutral
3Bullish
4Neutral
3Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Monte Rosa Therapeutics’s (GLUE) Moving Averages Convergence Divergence (MACD) indicator is 1.21, suggesting Monte Rosa Therapeutics is a Sell.
Monte Rosa Therapeutics’s (GLUE) 20-Day exponential moving average is 8.55, while Monte Rosa Therapeutics’s (GLUE) share price is $10.31, making it a Buy.
Monte Rosa Therapeutics’s (GLUE) 50-Day exponential moving average is 7.03, while Monte Rosa Therapeutics’s (GLUE) share price is $10.31, making it a Buy.

Monte Rosa Therapeutics (GLUE) Pivot Points

Oct 18, 2025, 11:24 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
8.58
9.39
9.85
10.66
11.12
11.93
12.39
Fibonacci
9.39
9.87
10.17
10.66
11.15
11.45
11.93
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Monte Rosa Therapeutics (GLUE) Moving Averages

Oct 18, 2025, 11:24 PM
Period
Simple
Exponential
MA5
10.50Sell
10.15Sell
MA10
9.37Buy
9.55Buy
MA20
8.24Buy
8.55Buy
MA50
6.29Buy
7.03Buy
MA100
5.63Buy
6.23Buy
MA200
5.53Buy
6.22Buy
Monte Rosa Therapeutics’s (GLUE) 10-Day exponential moving average is 9.55, while Monte Rosa Therapeutics’s (GLUE) share price is $10.31, making it a Buy.
Monte Rosa Therapeutics’s (GLUE) 100-Day exponential moving average is 6.23, while Monte Rosa Therapeutics’s (GLUE) share price is $10.31, making it a Buy.
Monte Rosa Therapeutics’s (GLUE) stock price is $10.31 and Monte Rosa Therapeutics’s (GLUE) 50-day simple moving average is 6.29, creating a Buy signal.
Monte Rosa Therapeutics’s (GLUE) stock price is $10.31 and Monte Rosa Therapeutics’s (GLUE) 100-day simple moving average is 5.63, creating a Buy signal.
Monte Rosa Therapeutics’s (GLUE) stock price is $10.31 and Monte Rosa Therapeutics’s (GLUE) 200-day simple moving average is 5.53, creating a Buy signal.

Monte Rosa Therapeutics (GLUE) Technical Indicators

Oct 18, 2025, 11:24 PM
Name
Value
Implied Action
RSI (14)
69.45
Neutral
STOCH (9,6)
79.51
Neutral
STOCHRSI (14)
80.21
Sell
MACD (12,26)
1.21
Sell
ADX (14)
62.03
Sell
Williams %R
-32.44
Buy
CCI (14)
97.56
Neutral
ATR (14)
0.64
-
Ultimate Oscillator
69.62
Neutral
ROC
37.48
Buy
Monte Rosa Therapeutics’s (GLUE) Relative Strength Index (RSI) is 69.45, creating a Neutral signal.
Monte Rosa Therapeutics’s (GLUE) Trend Strength Indicator (ADX) is 62.03, creating a Sell signal.
Monte Rosa Therapeutics’s (GLUE) Commodity Channel Index (CCI) is 97.56, creating a Neutral signal.
Monte Rosa Therapeutics’s (GLUE) Price Rate of Change (ROC) is 37.48, creating a Buy signal.

FAQ

Is GLUE a Buy, Hold, or Sell?
Based on GLUE’s technical indicators, GLUE is a Buy.
    What is GLUE’s RSI (14)?
    GLUE’s RSI (14) is 69.45, which suggests GLUE is a Neutral.
      What is GLUE’s MACD?
      GLUE’s MACD is 1.21, which suggests GLUE is a Sell.
        What is GLUE’s 5-day moving average?
        GLUE’s 5-day moving average is 10.50, which suggests GLUE is a Sell.
          What is GLUE’s 20-day moving average?
          GLUE 20-day moving average is 8.24, which suggests GLUE is a Buy.
            What is GLUE’s 50-day moving average?
            GLUE’s 50-day moving average is 6.29, which suggests GLUE is a Buy.
              What is GLUE’s 200-day moving average?
              GLUE’s 200-day moving average is 5.53, which suggests GLUE is a Buy.
                What is GLUE’s Williams % R (14)?
                GLUE’s Williams % R (14) is -32.44, which suggests GLUE is a Buy.
                  What is GLUE’s CCI (14)?
                  GLUE’s CCI (14) is 97.56, which suggests GLUE is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis